Ritika Kundra

74.2k total citations
22 papers, 539 citations indexed

About

Ritika Kundra is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ritika Kundra has authored 22 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ritika Kundra's work include Cancer Genomics and Diagnostics (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Genetic factors in colorectal cancer (6 papers). Ritika Kundra is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Genetic factors in colorectal cancer (6 papers). Ritika Kundra collaborates with scholars based in United States, Netherlands and Italy. Ritika Kundra's co-authors include Nikolaus Schultz, Tom W. Muir, Jianjiong Gao, C. David Allis, Lijuan Feng, Alexey A. Soshnev, John D. Bagert, Benjamin A. Nacev, Jaclyn F. Hechtman and Maurizio Scaltriti and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Ritika Kundra

21 papers receiving 534 citations

Peers

Countries citing papers authored by Ritika Kundra

Since Specialization

Citations

This map shows the geographic impact of Ritika Kundra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritika Kundra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritika Kundra more than expected).

Fields of papers citing papers by Ritika Kundra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritika Kundra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritika Kundra. The network helps show where Ritika Kundra may publish in the future.

Co-authorship network of co-authors of Ritika Kundra

This figure shows the co-authorship network connecting the top 25 collaborators of Ritika Kundra. A scholar is included among the top collaborators of Ritika Kundra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritika Kundra. Ritika Kundra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers 2025 ·npj Precision Oncology ·(unknown), (unknown), Ino de Bruijn, Ritika Kundra, Ramyasree Madupuri, Jianjiong Gao, Nikolaus Schultz, Gerrit A. Meijer, Jaap Heringa, Remond J.A. Fijneman, Sanne Abeln	1
2	Genetic Ancestry–Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies 2025 ·JAMA Oncology ·Kanika Arora, Sarah P. Suehnholz, Hongxin Zhang, Irina Ostrovnaya, Ritika Kundra, Subhiksha Nandakumar, Moriah H. Nissan, A. Rose Brannon, Chaitanya Bandlamudi, Marc Ladanyi, Alexander Drilon, Carol L. Brown, David B. Solit, Nikolaus Schultz, (unknown), Debyani Chakravarty	3
3	Tracking the FDA precision oncology drug approval landscape in OncoKB. 2024 ·Journal of Clinical Oncology ·Sarah P. Suehnholz, Ritika Kundra, Hongxin Zhang, Moriah H. Nissan, (unknown), (unknown), Nicole Fernandez, Subhiksha Nandakumar, Maria E. Arcila, Marc Ladanyi, Michael F. Berger, Aijazuddin Syed, A. Rose Brannon, Ross L. Levine, Ahmet Doǧan, Alexander Drilon, David B. Solit, Nikolaus Schultz, Debyani Chakravarty	1
4	Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors 2024 ·Annals of Surgical Oncology ·Michael Offin, (unknown), (unknown), Jennifer L. Sauter, Georgios Karagkounis, (unknown), Andrea Cercek, Ritika Kundra, Yanming Zhang, (unknown), (unknown), Marc Ladanyi, Garrett M. Nash, Marjorie G. Zauderer	2
5	Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms 2024 ·Endocrine Related Cancer ·(unknown), Ronak Shah, Joanne F. Chou, Ritika Kundra, (unknown), (unknown), (unknown), (unknown), Michael F. Berger, Diane Reidy‐Lagunes, Nitya Raj	2
6	Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection 2021 ·Clinical Cancer Research ·Joshua S. Jolissaint, Kevin C. Soares, Kenneth Seier, Ritika Kundra, Mithat Gönen, (unknown), Thomas Boerner, Carlie Sigel, Ramyasree Madupuri, Efsevia Vakiani, Andrea Cercek, James J. Harding, Nancy E. Kemeny, Louise C. Connell, Vinod P. Balachandran, Michael I. D’Angelica, Jeffrey A. Drebin, T. Peter Kingham, Alice C. Wei, William R. Jarnagin	30
7	Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy. 2021 ·Journal of Clinical Oncology ·Jessica A. Lavery, Samantha Brown, Gregory J. Riely, Philippe L. Bédard, Ben Ho Park, Jeremy L. Warner, Kenneth L. Kehl, Eva M. Lepisto, Hira Rizvi, Michele L. Lenoue-Newton, Caroline G. McCarthy, Celeste Yu, Ritika Kundra, Brooke Mastrogiacomo, Nikolaus Schultz, Julia E. Rudolph, Shawn M. Sweeney, Deborah Schrag, Katherine S. Panageas	1
8	Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia. 2020 ·Journal of Clinical Oncology ·Walid K. Chatila, Henry Walch, Jamal Benhamida, Jaclyn F. Hechtman, Francisco M. Barriga, Ritika Kundra, (unknown), Vincent A. Miller, Karuna Ganesh, David M. Faleck, Nikolaus Schultz, Laura H. Tang, David P. Kelsen, Rona Yaeger	6
9	Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling 2020 ·JCO Clinical Cancer Informatics ·Stacy B. Thomas, Tara M. Lichtenberg, Kristen K. Dang, Michael Fitzsimons, Robert L. Grossman, Ritika Kundra, Jessica A. Lavery, Michele L. Lenoue-Newton, Katherine S. Panageas, Charles L. Sawyers, Nikolaus Schultz, S. Joseph Sirintrapun, Ümit Topaloĝlu, (unknown), Thomas Yu, Ahmet Zehir, Stuart M. Gardos	1
10	Abstract 3208: OncoKB, a precision oncology knowledgebase 2020 ·Cancer Research ·Sarah P. Suehnholz, Hongxin Zhang, Moriah H. Nissan, Ritika Kundra, (unknown), Lindsay M. LaFave, Kinisha Gala, Chad Vanderbilt, Maria E. Arcila, Marc Ladanyi, Michael F. Berger, Ahmet Zehir, Julia E. Rudolph, Paul Sabbatini, Ross L. Levine, Ahmet Doǧan, Jianjiong Gao, David B. Solit, Nikolaus Schultz, Debyani Chakravarty	0
11	Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer 2019 ·Clinical Cancer Research ·Megan Greally, Joanne F. Chou, Walid K. Chatila, (unknown), Marinela Capanu, Jaclyn F. Hechtman, Yaelle Tuvy, Ritika Kundra, Foysal Daian, Marc Ladanyi, David P. Kelsen, David H. Ilson, Michael F. Berger, Laura H. Tang, David B. Solit, Luis A. Díaz, Nikolaus Schultz, Yelena Y. Janjigian, Geoffrey Y. Ku	75
12	TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations 2019 ·Clinical Cancer Research ·Ezra Y. Rosen, Debra A. Goldman, Jaclyn F. Hechtman, Ryma Benayed, Alison M. Schram, Emiliano Cocco, Sophie Shifman, Yixiao Gong, Ritika Kundra, James P. Solomon, Alberto Bardelli, Maurizio Scaltriti, Alexander Drilon, Alexia Iasonos, Barry S. Taylor, David M. Hyman	115
13	The expanding landscape of ‘oncohistone’ mutations in human cancers 2019 ·Nature ·Benjamin A. Nacev, Lijuan Feng, John D. Bagert, (unknown), Jianjiong Gao, Alexey A. Soshnev, Ritika Kundra, Nikolaus Schultz, Tom W. Muir, C. David Allis	257
14	FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer 2018 ·Clinical Colorectal Cancer ·Sebastián Mondaca, Walid K. Chatila, ‬David D. B. Bates, Jaclyn F. Hechtman, Andrea Cercek, Neil H. Segal, Zsofia K. Stadler, Anna M. Varghese, Ritika Kundra, Marinela Capanu, Jinru Shia, Nikolaus Schultz, Leonard B. Saltz, Rona Yaeger	18
15	Tumor mutation burden (TMB) and immune-related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC). 2018 ·Journal of Clinical Oncology ·Megan Greally, Walid K. Chatila, (unknown), Jaclyn F. Hechtman, Yaelle Tuvy, Ritika Kundra, Marc Ladanyi, David P. Kelsen, David H. Ilson, Michael F. Berger, Laura H. Tang, David B. Solit, Nikolaus Schultz, Yelena Y. Janjigian, Geoffrey Y. Ku	2
16	Variability in genomic alterations between right- and left-sided microsatellite stable (MSS) metastatic colorectal cancer and impact on survival. 2017 ·Journal of Clinical Oncology ·Rona Yaeger, Walid K. Chatila, Marla Lipsyc, Francisco Sánchez-Vega, Jaclyn F. Hechtman, Andrea Cercek, Zsofia K. Stadler, Sumit Middha, Ritika Kundra, Aijazuddin Syed, Ahmet Zehir, Anna M. Varghese, Neil H. Segal, Efsevia Vakiani, Marc Ladanyi, Michael F. Berger, Nancy E. Kemeny, Jinru Shia, Leonard B. Saltz, Nikolaus Schultz	1
17	Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients. 2017 ·Journal of Clinical Oncology ·Geoffrey Y. Ku, Francisco Sánchez-Vega, Walid K. Chatila, (unknown), (unknown), David H. Ilson, Jaclyn F. Hechtman, Yaelle Tuvy, Nancy Bouvier, Ritika Kundra, Jinru Shia, Zachary Heins, Sumit Middha, Ahmet Zehir, Marc Ladanyi, Michael F. Berger, Laura H. Tang, David B. Solit, Nikolaus Schultz, Yelena Y. Janjigian	7
18	The long tail of significantly mutated genes in prostate cancer. 2017 ·Journal of Clinical Oncology ·Joshua Armenia, Stephanie A. Mullane, Jianjiong Gao, Debyani Chakravarty, Ritika Kundra, Franklin W. Huang, G. Celine Han, Dan R. Robinson, Levi A. Garraway, Peter S. Nelson, Mark A. Rubin, Mary‐Ellen Taplin, Wassim Abida, Charles L. Sawyers, Arul M. Chinnaiyan, Philip W. Kantoff, Johann S. de Bono, Nikolaus Schultz, Eliezer M. Van Allen	1
19	Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade 2016 ·Annals of Oncology ·Y. Y. Janjigian, Francisco Sánchez-Vega, Philip Jonsson, Yaelle Tuvy, Nancy Bouvier, Jamie C. Riches, Ritika Kundra, Geoffrey Y. Ku, Jaclyn F. Hechtman, David P. Kelsen, Laura H. Tang, David H. Ilson, Efsevia Vakiani, Zsofia K. Stadler, Margaret K. Callahan, David B. Solit, Michael F. Berger, Barry S. Taylor, Nikolaus Schultz	3
20	OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer. 2016 ·Journal of Clinical Oncology ·Debyani Chakravarty, Sarah Phillips, Jianjiong Gao, Ritika Kundra, Hongxin Zhang, Julia E. Rudolph, Rona Yaeger, Tara E. Soumerai, Moriah H. Nissan, Sarat Chandarlapaty, Tiffany A. Traina, Paul K. Paik, Alan L. Ho, Feras Hantash, Andrew Grupe, (unknown), Marc Ladanyi, David B. Solit, Paul Sabbatini, Nikolaus Schultz	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact